Do Direct-to-Consumer Pharmacies Present More Challenges for Patients?
Commentary cites lower control over health plan costs and the potential bias for prescribing drugs through influence from drug manufacturers.
October 24, 2026
Commentary cites lower control over health plan costs and the potential bias for prescribing drugs through influence from drug manufacturers.